Pharma Foods International Co., Ltd.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Pharma Foods International Co., Ltd.'s yearly results, compared with Healthcare companies in Japan. Tap ? on any ratio for what it means.
Where ¥100 of sales goes
Latest year (Jul 2024). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
—Data incomplete
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
0.4×Debt due within a year is covered 0.4 times by its yearly operating cash.
Lower than 63% of Healthcare companies in Japan.
Cash Cushion Ratio
−7%Debt, after subtracting cash, equals 7% of its market value (net debt).
Lower than 64% of Healthcare companies in Japan.
Tangible Assets Ratio
100%Of every ¥100 the company owns, ¥100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 79% of Healthcare companies in Japan.
Tangible Net Worth Ratio
98%Of every ¥100 of net worth, ¥98 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 74% of Healthcare companies in Japan.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (8)
Pharma Foods International Co., Ltd. owes ¥0.70 for every ¥1 it owns.
Compared with Healthcare companies in Japan · latest annual results Jul 2026.
P/E ratio
9.3Investors pay ¥9.3 for every ¥1 of Pharma Foods International Co., Ltd.'s yearly profit, lower than 88% of Healthcare companies in Japan.
P/B ratio
1.41The share price is 1.41 times Pharma Foods International Co., Ltd.'s book value per share, lower than 57% of Healthcare companies in Japan.
Market cap
¥18.6 BThe total market value of all of Pharma Foods International Co., Ltd.'s shares at today's price (share price × number of shares), larger than 51% of Healthcare companies in Japan. PosiCap size class: Mini Cap.
Net worth (book value)
¥9.8 BWhat Pharma Foods International Co., Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Jan 2026).
Book value per share
¥336.39Net worth divided by the number of shares. The share price of ¥639.00 is 1.9 times this, which is the P/B above.
Return on equity (ROE)
16.1%Pharma Foods International Co., Ltd. earned 16.1% on its shareholders' money over the last year, higher than 83% of Healthcare companies in Japan.
Owes vs Owns
0.70×Pharma Foods International Co., Ltd. owes ¥0.70 for every ¥1 it owns (moderate), higher than 85% of Healthcare companies in Japan.
Dividend yield
3.93%Pharma Foods International Co., Ltd. pays 3.93% of its share price as dividends a year, higher than 82% of dividend-paying Healthcare companies in Japan.
Questions
What is Pharma Foods International Co., Ltd.'s P/E ratio?
Investors pay ¥9.3 for every ¥1 of Pharma Foods International Co., Ltd.'s yearly profit, lower than 88% of Healthcare companies in Japan.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Pharma Foods International Co., Ltd.: ¥18.6 B ÷ ¥9.8 B (31 Jan 2026) = 1.9.
What is Pharma Foods International Co., Ltd.'s return on equity?
Pharma Foods International Co., Ltd. earned 16.1% on its shareholders' money over the last year, higher than 83% of Healthcare companies in Japan.
How much does Pharma Foods International Co., Ltd. owe compared with what it owns?
Pharma Foods International Co., Ltd. owes ¥0.70 for every ¥1 it owns (moderate), higher than 85% of Healthcare companies in Japan.
Does Pharma Foods International Co., Ltd. pay a dividend?
Yes. Pharma Foods International Co., Ltd. pays 3.93% of its share price as dividends a year, higher than 82% of dividend-paying Healthcare companies in Japan.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.